EU’s first innovation hub to be run from Flemingsberg

Health Data Sweden (HDS) will be the first among the EU’s new digital innovation hubs. The initiative is managed by Sebastiaan Meijer, Deputy Head of School at KTH in Flemingsberg.

The goal of HDS is to promote the use of health data to contribute to more efficient healthcare outcomes. The concept of health data includes information collected by healthcare providers, from individuals with the help of various sensors and health apps, and from research.

By combining different health data, it is possible to increase knowledge about individual conditions, identify new treatment methods and contribute to better diagnoses. Health data is believed to be a key factor in the growing field of precision medicine.

“Currently, the health data landscape is highly fragmented. There is a large number of good, smaller initiatives nationally and within the EU. But the exchange and access to health data is very limited. We also need to gather knowledge about how to best use and administer health data,” says Meijer.

One example of how health data is changing and simplifying care is a mobile app that growing numbers of health centres are using to provide faster answers to whether a change in a person’s skin could be due to cancer.

In Sweden, access to health data is primarily a regional issue, which slows its use and dissemination.
“We hope that the HDS consortium can lead to a breakthrough in usage by better co-ordinating data collection and dissemination. Our goal is to contribute to greater incentives for everyone to make available and share their health data throughout Europe,” Meijer says.

The HDS initiative brings together 18 partners across the country, such as universities, regional authorities, innovation environments and research institutes. HDS has recevied funding amounting to six million euros over three years.

Published On: 13 September 2022
  • Now Open: Flemingsberg Science Award STARTUP 2026

    Do you have a business idea that can make a difference, locally or globally? Flemingsberg Science Award STARTUP is the competition for those who want to challenge their idea, gain valuable feedback from experienced experts, and take the first step toward building something real. 

  • Campus Flemingsberg continues to grow – more students and strong collaboration in focus

    Campus Flemingsberg remains one of Sweden’s most dynamic knowledge environments. Over the past year, the number of students has increased from 24,000 to approximately 27,000. The trend is clear: the campus’s broad academic profile continues to attract a growing number of students.

  • Limitless Potential: Winner of the Flemingsberg Science Award 2025

    Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.

  • Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future

    In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.

  • En nationell resurs för morgondagens behandlingar – nu är Karolinska ATMP Centrum invigt

    Med ett tydligt budskap om framtidstro och ett kraftfullt samarbete invigdes Karolinska ATMP Centrum i Flemingsberg i slutet av augusti. Centret är ett samarbete mellan Karolinska Institutet och Karolinska Universitetssjukhuset, och kommer fungera som en nationell resurs för tillverkning av avancerade terapier (ATMP), där forskning, kliniska prövningar och behandlingar smidigt samverkar för att leverera banbrytande terapier till patienter.